Evidence map›Paper›PMID 31562245›Full record

ArticleThe Journal of biological chemistry2019

Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45).

Abbey L Perl, Caitlin M O'Connor, Pengyan Fa, Franklin Mayca Pozo, Junran Zhang, Youwei Zhang, Goutham Narla

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Abbey L PerlDepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.ORCID 0000-0002-4093-1833
Caitlin M O'ConnorDepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.ORCID 0000-0002-7840-6399
Pengyan FaDepartment of Radiation Oncology, Ohio State University James Comprehensive Cancer Center and College of Medicine, Columbus, Ohio 43210.
Franklin Mayca PozoDepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
Junran ZhangDepartment of Radiation Oncology, Ohio State University James Comprehensive Cancer Center and College of Medicine, Columbus, Ohio 43210.
Youwei ZhangDepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
Goutham NarlaDepartment of Internal Medicine, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106 gnarla@med.umich.edu.ORCID 0000-0003-4098-4203
University School · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USCase Western Reserve University · US

Funding

Structural and molecular determinants of protein phosphatase 2A in Alzheimer's DiseaseR01CA240993 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NARLA, GOUTHAM, TAYLOR, DEREK JAMES · 2019 to 2023
$3.4M
Targeting DNA repair in KRAS mutated lung cancer by chemical screeningR01CA230453 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ZHANG, YOU-WEI · 2019 to 2023
$2.4M
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer TherapyR01CA181654 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NARLA, GOUTHAM · 2015 to 2019
$1.9M
Defining the role of the PR72 regulatory subunit in small molecule mediated activation of PP2A's tumor suppressive activityF31CA213554 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI PERL, ABBEY LEIGH · 2017 to 2018
$71k
NCI NIH HHS F31 CA213554NCI NIH HHS R01 CA181654NCI NIH HHS R01 CA230453NCI NIH HHS R01 CA240993
6 · The paper itself

Abstract

Genomic replication is a highly regulated process and represents both a potential benefit and liability to rapidly dividing cells; however, the precise post-translational mechanisms regulating genomic replication are incompletely understood. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that regulates a diverse array of cellular processes. Here, utilizing both a gain-of-function chemical biology approach and loss-of-function genetic approaches to modulate PP2A activity, we found that PP2A regulates DNA replication. We demonstrate that increased PP2A activity can interrupt ongoing DNA replication, resulting in a prolonged S phase. The impaired replication resulted in a collapse of replication forks, inducing dsDNA breaks, homologous recombination, and a PP2A-dependent replication stress response. Additionally, we show that during replication, PP2A exists in complex with cell division cycle 45 (CDC45) and that increased PP2A activity caused dissociation of CDC45 and polymerase α from the replisome. Furthermore, we found that individuals harboring mutations in the PP2A Aα gene have a higher fraction of genomic alterations, suggesting that PP2A regulates ongoing replication as a mechanism for maintaining genomic integrity. These results reveal a new function for PP2A in regulating ongoing DNA replication and a potential role for PP2A in the intra-S-phase checkpoint.

Indexed as

DNA ReplicationAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TumorCell Transformation, NeoplasticDNA DamageEnzyme ActivationFemaleMiceProtein BindingProtein Phosphatase 2S PhaseAtaxia Telangiectasia Mutated ProteinsATR protein, humanCDC45 protein, humanCell Cycle ProteinsProtein Phosphatase 2cell cyclecell cycle checkpointcell division cycle 45 (CDC45)DNA damage responseDNA-protein interactionDNA replicationgenome stabilityprotein phosphatase 2 (PP2A)replisomesmall molecule activator of PP2A (SMAP)

Identifiers

PMID31562245
PMCPMC6851307
OpenAlexW2976524863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.